Michael LaRiviere, MD
Radiation Oncology
Headshot of Michael LaRiviere, MD

Michael LaRiviere, MD

Radiation Oncology
Accepting new patients
Sees patients of all ages
Penn Radiation Oncology Perelman - 2nd Floor
Headshot of Michael LaRiviere, MD
Penn Medicine Provider

About me

  • Assistant Professor of Radiation Oncology at the Hospital of the University of Pennsylvania

My education and training

  • Emory UniversityMedical School
  • University of Pennsylvania Health SystemResidency

Spoken languages

English
English

Reviews

Average Rating

88 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
July 2026
dr. la riviere seems like a doctor who cares a lot about his patients and the quality of the care/treatment they receive.
Anonymous
April 2026
very thorough explaining everything
Anonymous
April 2026
very likely
Anonymous
March 2026
personable but still direct

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
Dr. LaRiviere is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Xin Tie, Sarah A Milgrom, Andrea C Lo, Anne-Marie Charpentier, Michael J LaRiviere, Danyal Maqbool, Steve Y Cho, Kara M Kelly, David Hodgson, Sharon M Castellino, Bradford S Hoppe, Tyler J Bradshaw Multimodality Artificial Intelligence for Involved-Site Radiation Therapy: Clinical Target Volume Delineation in High-Risk Pediatric Hodgkin Lymphoma , Int J Radiat Oncol Biol Phys .: 2026


Hollawell C, Zhang S, Messing I, Santos AG, Baron J, Friedes C, Min L, Eisenberg R, Khullar K, Maxwell R, Bradley J, Deville C Jr, Metz J, Feigenberg S, Busch T, LaRiviere M Proton Therapy Utilization Among Adult Cancer Patients , Int J Part Ther: 2026


Baron JA, Chelius M, Singh G, Schad MD, Berger M, Chong ER, Thomas CJ, Carter JS, Cook MR, Nasta SD, Landsburg DJ, Barta SK, Svoboda J, Schuster SJ, Yegya-Raman N, LaRiviere MJ, Plastaras JP, Chong EA, Hubbeling H. Safe Integration of Radiation Therapy With Bispecific Antibodies in Relapsed/Refractory B-cell Lymphomas , Clin Lymphoma Myeloma Leuk: 2026


Song JH, Baron J, Perez CC, Ramesh S, Minturn J, Desai KA, Shah AC, Belasco JM, Cole KA, Fisher MJ, Storm PB, Madsen PM, Kurtz G, Lustig RA, Hill-Kayser C, LaRiviere MJ Feasibility and safety of proton re-irradiation in recurrent pediatric CNS tumors: A single-institution retrospective study , Pediatr Blood Cancer: 2026


Thomas CJ, Myers CS, Chung J, Landsburg D, Nasta SD, Svoboda J, Chong EA, Schuster SJ, Carter J, Cook M, Tomasulo E, Elghawy O, LaRiviere M, Hubbeling H, Plastaras JP, Rook AH, Villasenor-Park J, Ruella M, Kim E, Barta SK Clinical features and outcomes of patients with non-erythrodermic mycosis fungoides with high blood tumor burden , Blood Neoplasia: 2026


Zhu, Yifeng, Lu, Baozhu, Xiong, Emily, Lai, Ching, Tang, Karen, Hubbeling, Harper G, Plastaras, John P, LaRiviere, Michael, Pogue, Brian W, Zhu, Timothy C Stereo Cherenkov imaging as 3D absolute dose monitoring tool for total skin electron therapy (TSET) , , 13841: 2026,69-75


Pomaville, Monica, Hwang, Hyojeong, Boulter, Alexis, Glisovic-Aplenc, Tina, Bommisetti, Praneeth, Oranges, Katelyn, Nelson, Brandi, Schubert, Jeffrey, Xu, Feng, Wu, Jinhua Abstract B008: Personalized antisense oligonucleotide treatment in a patient with relapsed NFIA:: CBFA2T3 acute myelogenous leukemia , Cancer Research, 86(1_Supplement): 2026,B008-B008


Patel, Heta, Hubbeling, Harper, Yu, Kyle, Carpenter, Maribel, LaRiviere, Michael J, Plastaras, John P, Cohen, Adam D, Kapur, Shivani, Vogl, Dan T, Waxman, Adam J Outcomes of radiation integrated with T-cell–engaging bispecific antibodies in relapsed/refractory multiple myeloma , Blood advances, 10(4): 2026,1395-1399


Kovalchuk, N, Simiele, E, LaRiviere, M, Hiniker, S, Soike, M, Han, C, Wong, J, Dandapani, S, Kumar, K, Parsons, D Incorporating Intensity Modulated Total Body Irradiation (IMRT-TBI) into Future Cooperative Group Clinical Trials: An NRG Hematologic Malignancies Working Group-Led Report from the National Clinical Trials Network , International Journal of Radiation Oncology* Biology* Physics: 2026


Jiang, Cecilia, Hoover, Travis, Baron, Jonathan, Han, Xiaoyan, Li, Bolin, Gao, Yin, Kim, Michele, Hubbeling, Harper, Chong, Elise A, Carter, Jordan, Svoboda, Jakub, Schuster, Stephen J, Landsburg, Daniel J, Nasta, Sunita D, Plastaras, John, LaRiviere, Michael Long Term Results of Proton Therapy in Adult Infradiaphragmatic Lymphoma , International Journal of Particle Therapy: 2026,101304


View all publications